Data updated: Mar 10, 2026
FERRIPROX
DEFERIPRONE
Approved 2011-10-14
6
Indications
--
Phase 3 Trials
14
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2011-10-14
- Routes
- ORAL
- Dosage Forms
- SOLUTION, TABLET
FERRIPROX Approval History
Loading approval history...
What FERRIPROX Treats
6 FDA approvalsOriginally approved for its first indication in 2011 . Covers 6 distinct patient populations.
- Other (6)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
FERRIPROX FDA Label Details
ProFERRIPROX Patents & Exclusivity
Latest Patent: Oct 2038
Exclusivity: Apr 2028
Patents (10 active)
US11723874
Expires Oct 25, 2038
US11357731
Expires Oct 25, 2038
US10940115
Expires Oct 25, 2038
US10780055
Expires Oct 25, 2038
US11458103
Expires Oct 25, 2038
US10940116
Expires Oct 25, 2038
US8703156
Expires Oct 26, 2029
Exclusivity
ODE-417
Until Apr 2028
ODE-418
Until Apr 2028
ODE-419
Until Apr 2028
ODE-417
Until Apr 2028
ODE-418
Until Apr 2028
Source: FDA Orange Book
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.